Skip to content

Post-FDA approval of imetelstat for MDS, several treatment implementation gaps remain
Defining the next steps in myelodysplastic syndromes
SOHO 2026: Pharma trials in lymphoma with Drs. Nastoupil, Shah
What can research funding entities do to help progress in MDS with Timothy Graubert, MD
SOHO invests in next generation of hematologic oncologists

Insider Reader Survey

Join SOHO

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Chronic Lymphocytic Leukemia

ASH 2025 Cellular Therapy Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Aggressive B-Cell Lymphomas

Dr. Avalos highlights ASH 2025 takeaways, the future of blood cancer

by Leah Sherwood
January 5, 2026
0 Comments

ASH 2025 Leukemia Chronic Lymphocytic Leukemia Meetings / Conferences News

Phase 3 study finds fixed-duration treatment non-inferior to continuous treatment in CLL

by Kerri Fitzgerald
December 7, 2025
0 Comments

Leukemia Chronic Lymphocytic Leukemia Lymphoma News

FDA grants traditional approval to pirtobrutinib in relapsed or refractory CLL/SLL

by SOHO Insider Editors
December 3, 2025
0 Comments

Leukemia News SOHO 2025 Leukemia Chronic Lymphocytic Leukemia

Obesity increases infection risk in CLL for patients treated with a BTKi

by Leah Sherwood
October 31, 2025
0 Comments

Leukemia Chronic Lymphocytic Leukemia SOHO Insider Podcast

Drs. O’Brien, Jain discuss FLAIR trial, BTK degraders in CLL

by Leah Sherwood
October 30, 2025
0 Comments

SOHO 2025 Leukemia Chronic Lymphocytic Leukemia Meetings / Conferences News

SOHO pilot program finds structured learning improves practice in R/R CLL/SLL

by SOHO Insider Editors
October 29, 2025
0 Comments

Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia News

Anthony G. Letai, MD, PhD, sworn in as NCI Director

by Leah Sherwood
September 29, 2025
0 Comments

Leukemia News SOHO 2025 Leukemia Chronic Lymphocytic Leukemia News

22-year study highlights disparities in CLL mortality rates

by SOHO Insider Editors
September 25, 2025
0 Comments

Leukemia Chronic Lymphocytic Leukemia

Birelentinib granted Fast Track designation by FDA for CLL/SLL

by SOHO Insider Editors
August 26, 2025
0 Comments

Leukemia Chronic Lymphocytic Leukemia News

Does CLL arise through a multiclonal selection process?

by Leah Sherwood
August 20, 2025
0 Comments

1
2
3

Top Categories

Cellular Therapy

81

Leukemia

130

Lymphoma

141

Multiple Myeloma

120

Myelodysplastic Syndromes

49

Myeloproliferative Neoplasms

36

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Chronic Lymphocytic Leukemia

Dr. Avalos highlights ASH 2025 takeaways, the future of blood cancer

Phase 3 study finds fixed-duration treatment non-inferior to continuous treatment in CLL

FDA grants traditional approval to pirtobrutinib in relapsed or refractory CLL/SLL

Obesity increases infection risk in CLL for patients treated with a BTKi

Drs. O’Brien, Jain discuss FLAIR trial, BTK degraders in CLL

SOHO pilot program finds structured learning improves practice in R/R CLL/SLL

Anthony G. Letai, MD, PhD, sworn in as NCI Director

22-year study highlights disparities in CLL mortality rates

Birelentinib granted Fast Track designation by FDA for CLL/SLL

Does CLL arise through a multiclonal selection process?

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

Post-FDA approval of imetelstat for MDS, several treatment implementation gaps remain

Defining the next steps in myelodysplastic syndromes

SOHO 2026: Pharma trials in lymphoma with Drs. Nastoupil, Shah

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

Chronic Lymphocytic Leukemia

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms